Chiome Bioscience Reports Large Exercise

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 20, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Chiome Bioscience Reports Large Exercise of Warrant Shares in January

Source disclosure: February 20, 2026 Chiome Bioscience Inc. [4583.T] TOKYO, Feb 20 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the large exercise of its 23rd warrant shares (exercise price adjustment clause attached) from February 1 to February 19, 2026. During this period, a total of 1,436,200 shares were exercised out of 14,362 warrants issued, representing an exercise ratio of 10.56%. As of the end of January, there were 122,100 warrants remaining unexercised, eq